(1S,3R)-dihydroxy-(20S)-[(5'R)-(2"-hydroxy-2"-propyl)-(2'S)-tetrahydrofuryl]-22,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin D3

Term ID

CHEBI:139029

Synonyms

(1R,3R,5Z,7E,9xi,20S)-20-[(2S,5R)-5-(2-hydroxypropan-2-yl)oxolan-2-yl]-9,10-secopregna-5,7,10-triene-1,3-diol

Definition

A hydroxycalciol that is a synthetic analogue of vitamin D3 which contains an oxolane ring and exhibits weak vitamin D receptor agonist activity.

References

PMID:28399453

Ontology

ChEBI ( EBI )

Relationships

is a type of: D3 vitamins hydroxycalciol oxolanes

D3 vitamins hydroxycalciol oxolanes Show first 5 Terms
has_role: vitamin D receptor agonist

vitamin D receptor agonist Show first 5 Terms

Phenotype

Phenotype resulting from (1S,3R)-dihydroxy-(20S)-[(5'R)-(2"-hydroxy-2"-propyl)-(2'S)-tetrahydrofuryl]-22,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin D3

Phenotype where environments contain (1S,3R)-dihydroxy-(20S)-[(5'R)-(2"-hydroxy-2"-propyl)-(2'S)-tetrahydrofuryl]-22,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin D3

Phenotype modified by environments containing (1S,3R)-dihydroxy-(20S)-[(5'R)-(2"-hydroxy-2"-propyl)-(2'S)-tetrahydrofuryl]-22,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin D3

Human Disease Model